In AD patients, low efficacy of antioxidant response, possibly involving PGC1α as a regulator and SOD2 as an effector, likely allows the vicious cycle linking Aβ, ROS, and oxidative damage to occur, leading to dementia progression. This evidence concerns the gene PPARGC1A and dementia.